"Buprenorphine Treatment Recommendations for Patients With Opioid Use Disorder," by Kristina Michaud, DO, Anesthesiology Resident; Harrison Plunkett, MD, Anesthesiology Chief Resident; and Lynn Kohan, MD, Associate Professor of Anesthesiology and Pain Medicine; all of the University of Virginia, Charlottesville, Virginia. From ASRA News, November 2021. See original article at www.asra.com/asra-news for figures and references. This material is copyrighted.    <a rel="payment" href="https://www.asra.com/about-asra/donate">Support the show</a>

ASRA News

Buprenorphine Treatment Recommendations for Patients With Opioid Use Disorder

ASRA News is the official newsletter of the American Society of Regional Anesthesia and Pain Medicine (ASRA). Published quarterly online (www.asra.com/asra-news) in February, May, August, and November, newsletter articles address hot topics in the field and provide an opportunity for regional anesthesiology and pain medicine physicians and healthcare providers to share their experiences and recommendations for various aspects of practice. The publication also includes organization news, updates, and meeting information. Note: Mention of specific products do not indicate or imply endorsement. Author opinions do not necessarily represent those of ASRA.

Buprenorphine Treatment Recommendations for Patients With Opioid Use Disorder

No transcript detected